Patents Assigned to Amano Enzyme USA Co., Ltd.
  • STABLE PROTEIN FORMULATIONS
    Publication number: 20220142210
    Abstract: Described herein are stable protein solutions that have a pH of from about 3.5 to about 7.0 and are stable against precipitation of the protein, as well as methods of making such stable protein solutions, and beverages and beverages additives for human or animal consumption comprising such stable protein solutions. These stable protein solutions comprise a protein, a stabilizer, and a protein deamidating enzyme.
    Type: Application
    Filed: February 25, 2020
    Publication date: May 12, 2022
    Applicants: AMANO ENZYME USA CO., LTD., AMANO ENZYME INC.
    Inventors: Theodore S. LIOUTAS, Keita OKUDA
  • Use of proteases for gluten intolerance
    Patent number: 9498520
    Abstract: The present technology relates to an enzyme composition. The enzyme composition may be used to treat gluten intolerant subjects, including suffering from non-Celiac gluten intolerance and/or non-Celiac gluten sensitivity. The enzyme composition may also be used to reduce gluten exposure in certain individuals. For example, the enzyme composition may also be used as a prophylactic to reduce exposure to gluten oligopeptides.
    Type: Grant
    Filed: January 9, 2015
    Date of Patent: November 22, 2016
    Assignees: AMANO ENZYME INC., AMANO ENZYME USA CO. LTD.
    Inventors: James F. Jolly, Horoki Ido, Hirotaka Matsubara, Tetsuya Takahashi, Kyoichi Nishio
  • Use of proteases for gluten intolerance
    Patent number: 9011842
    Abstract: The present technology relates to an enzyme composition. The enzyme composition may be used to treat gluten intolerant subjects, including suffering from non-Celiac gluten intolerance and/or non-Celiac gluten sensitivity. The enzyme composition may also be used to reduce gluten exposure in certain individuals. For example, the enzyme composition may also be used as a prophylactic to reduce exposure to gluten oligopeptides.
    Type: Grant
    Filed: February 2, 2011
    Date of Patent: April 21, 2015
    Assignees: Amano Enzyme Inc., Amano Enzyme USA Co., Ltd.
    Inventors: James F. Jolly, Horoki Ido, Hirotaka Matsubara, Tetsuya Takahashi, Kyoichi Nishio
  • Enzyme inhibitors of PAI-1
    Patent number: 8066991
    Abstract: The invention provides a method for the treatment of a subject suffering from a cardiovascular disease using a therapeutically effective amount of at least one enzyme that is capable of inhibiting PAI-1 activity. The invention also provides a method of decreasing the risk of the occurrence of a cardiovascular disease in a subject who presents at least one risk factor that is associated with a cardiovascular disease, by administering to the subject a therapeutically effective amount of at least one enzyme that is capable of inhibiting PAI-1 activity. Additionally, the invention provides a method of inhibiting PAI-1 activity in a subject in need thereof, where the subject is administered an enzyme selected from a protease or peptidase.
    Type: Grant
    Filed: October 10, 2006
    Date of Patent: November 29, 2011
    Assignees: Amano Enzyme USA Co., Ltd., Amano Enzyme Inc.
    Inventor: James F. Jolly